March 23 (Reuters) - Daiichi Sankyo Co Ltd:
* STARTED FIRST VACCINATIONS IN A PHASE 1/2 CLINICAL TRIAL IN JAPAN OF AN MRNA COVID-19 VACCINE BEING DEVELOPED BY CO Source text : (https://bit.ly/3tKwxfH) Further company coverage:
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,339 JPY | +0.28% | +0.07% | +37.89% |
07/05 | Japan's Nikkei closes at 3-week high on US rate-cut outlook, tech boost | RE |
07/05 | Japan's Nikkei climbs on Fed rate-cut outlook, tech boost | RE |
March 23 (Reuters) - Daiichi Sankyo Co Ltd:
* STARTED FIRST VACCINATIONS IN A PHASE 1/2 CLINICAL TRIAL IN JAPAN OF AN MRNA COVID-19 VACCINE BEING DEVELOPED BY CO Source text : (https://bit.ly/3tKwxfH) Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+37.89% | 68.52B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |